NSPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
InspireMD Inc (NSPR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently oversold, as indicated by the RSI, but technical indicators such as MACD and moving averages suggest a bearish trend. While the company's revenue and gross margin have shown significant improvement in the latest quarter, the negative EPS and net income remain concerns. Additionally, there are no strong trading signals or recent positive news catalysts to support immediate buying action.
The stock is in a bearish trend with MACD below zero and negatively expanding, RSI at 15.437 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are S1: 1.269 and S2: 1.229, while resistance levels are R1: 1.399 and R2: 1.439.
Analyst coverage initiated with a Buy rating and a $6 price target.
Net income remains negative at -$11.76M, and EPS dropped by -26.32% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress. Bearish technical indicators and no strong proprietary trading signals.
In Q4 2025, revenue increased to $3.15M (up 61.57% YoY), net income improved to -$11.76M (up 28.20% YoY), EPS dropped to -0.14 (-26.32% YoY), and gross margin increased to 37.47% (up 55.74% YoY).
Maxim initiated coverage with a Buy rating and a $6 price target on 2026-02-02.
